The largest database of trusted experimental protocols

Apc cd11b antibody

Manufactured by BioLegend
Sourced in United States

The APC CD11b Antibody is a fluorochrome-conjugated antibody that binds to the CD11b antigen, a surface molecule expressed on various immune cells such as monocytes, macrophages, and granulocytes. This antibody can be used for the identification and analysis of CD11b-positive cells in flow cytometry applications.

Automatically generated - may contain errors

3 protocols using apc cd11b antibody

1

Tumor Tissue Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The right untreated tumor was extracted, immersed in digestion solution and incubated at 37 °C for 1 h. The cell suspension was then filtered through a 40 µm filter to remove debris and cell clumps. The cells were washed with PBS and resuspended. The cell concentration was adjusted to 1 × 10 7 /ml in l00 µl for examination. The corresponding surface antibodies (1:200) were added and incubated on ice in the dark for 20 min for surface antibody staining. After surface antibody staining was completed, 60 µl of cytokine fixation solution was added and fixed on ice in the dark for 20 min. The cells were washed twice with cytokine permeabilization buffer, and cytokine staining antibodies (1:200) were prepared with cytokine permeabilization buffer. The cells were incubated on ice in the dark for 25 min for cytokine staining. Anti-mouse FITC CD45 Antibody, PerCP/ Cyanine5.5 CD4 Antibody, PE/Cyanine7 CD8a Antibody, PE FOXP3 Antibody, FITC Ly-6G/Ly-6C (Gr-1) Antibody, APC CD11b Antibody (Biolegend, USA) were used. Detection was performed on a Beckman Coulter (USA) flow cytometer, and the percentages of immune cells and immunosuppressive cells in right tumor tissues were analyzed by CytExpert software.
+ Open protocol
+ Expand
2

Non-Adherent Cell Drug Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
For non-screen drug plating, 2.5–5×103 live cells were seeded onto flat-bottom 96-well plastic plates in 200 μL of media per well. Drugs were added such that the total DMSO (Sigma-Aldrich) concentration was the same for all wells. After treatment, plates were transferred onto round-bottom 96-well plastic plates (Greiner Bio-One). Cells were analyzed on an iQue Screener Plus-VBR flow cytometer with a similar gating strategy as the one used for the screen, except we isolated singlets using both height and area parameters for FSC and SSC from live cells. We then isolated GFP + or antibody-positive events from the live singlets. GSK-LSD1, mercaptopurine (Tocris), cerulenin (Cayman Chemical), 6-thioguanine (Cayman Chemical), guanosine (Cayman Chemical), TOFA (MedChemExpress), ND-630 (MedChemExpress), hypoxanthine (Sigma Aldrich), and 13C5-hypoxanthine (Cambridge Isotope Laboratories) were dissolved in DMSO as 10mM stocks. Tranylcypromine (Sigma Aldrich) and homocysteine (Sigma Aldrich) were dissolved in ethanol and water respectively as 100mM stock. APC-CD11b antibody (BioLegend) and propidium iodide (ThermoFisher) were used at concentrations of 1 μg/mL or 50 μg/mL respectively.
+ Open protocol
+ Expand
3

Cytarabine-resistant Leukemia Cell Culture and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Molm13 (M13), Molm14 (M14) and the relatively Cytarabine‐resistant cell lines OCI‐AML3 and THP‐137 were obtained from the Deutsche Sammlung von Mikroorganismen und Zellkulturen (Braunschweig, Germany). All cells were cultured in RPMI1640 medium with 10% FBS and 100 U/mL streptomycin/penicillin in a humidified atmosphere at 37°C and 5% CO2. Quizartinib and Cytarabine were purchased from Selleck Chemicals, dissolved in dimethyl sulphoxide (DMSO) at stock concentrations of 10 mM and stored at −80°C. The dual CA IX/XII inhibitors FC531 and SLC0111 were synthesised as previously described.22 The dual CA IX/XII inhibitor CA912 was purchased from Calbiochem (Calbiochem Research Biochemicals, Burlington, MA). All CA IX/XII inhibitors were dissolved in DMSO at stock concentrations 10 mM and stored at −80°C. Fluorescein isothiocyanate‐AnnexinV antibody and propidium iodide were purchased from BD Pharmingen (556420) and Sigma‐Aldrich (P4864), respectively. APC‐CD11b antibody was purchased from Biolegend (101212).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!